Sandra S Pinho

US Patent:

20200270349, Aug 27, 2020

Filed:

Jan 27, 2020

Appl. No.:

16/773907

Inventors:

- Bronx NY, US
Sandra PINHO - New York NY, US
Qiaozhi WEI - Bronx NY, US
Sung Kyun LEE - Bronx NY, US

Assignee:

Albert Einstein College of Medicine - Bronx NY

International Classification:

C07K 16/28
A61P 35/02

Abstract:

Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.

US Patent:

20190077878, Mar 14, 2019

Filed:

Nov 26, 2018

Appl. No.:

16/199555

Inventors:

- BRONX NY, US
SANDRA PINHO - NEW YORK NY, US
QIAOZHI WEI - BRONX NY, US

Assignee:

ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. - BRONX NY

International Classification:

C07K 16/30
A61P 35/02
C07K 16/28

Abstract:

Methods are disclosed for treating cancers using antibodies and antibody fragments that inhibit the activity of Vascular cell adhesion molecule 1 (Vcam1) and/or Macrophage erythroblast attacher (Maea).

US Patent:

20150238532, Aug 27, 2015

Filed:

Jul 1, 2013

Appl. No.:

14/416078

Inventors:

- Bronx NY, US
Sandra Pinho - Bronx NY, US
Julie Lacombe - Bronx NY, US

Assignee:

ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY - Bronx NY

International Classification:

A61K 35/28
C12N 5/0775

Abstract:

A method of obtaining a population of PDGFRα CD51 CD146stem cells is provided. Compositions comprising PDGFRα CD51 CD146stem cells, and methods of use of a population of PDGFRαCD51 CD146stem cells, are also provided.